News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
CSL Limited has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings to access its late stage, next-generation self-amplifying mRNA (sa-mRNA) vaccine tech: prepared to spend more than $4bn on the deal to accelerate its...
Polyplus has partnered with ENCell in Korea for optimized commercial scale viral vector manufacturing.
Shares of Catalent Inc plunged yesterday after the contract development and manufacturing organization (CDMO) reported fiscal first-quarter profit and revenue that missed expectations. The company also scaled back its full-year outlook.
Novavax, Sk bioscience and Aspen Neuroscience are among the companies welcoming new faces to top jobs.